Tuesday 18 May 2021
Home      All news      Contact us      RSS      India
dailyexcelsior.com - 26 days ago

Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection

New Delhi, Apr 22: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. Caplin Steriles Ltd (Caplin) has been granted [ ] The post Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection appeared first on Jammu Kashmir Latest News | Tourism | Breaking News J K.


Latest News
Hashtags:   

Caplin

 | 

Point

 | 

Laboratories

 | 

USFDA

 | 

Neostigmine

 | 

Methylsulfate

 | 

Injection

 | 

Sources